HIGHLIGHTS
- who: Yongchang Xu et al. from the University School of Medicine, Hangzhou, Zhejiang, The People`s Republic of China, Shanghai Public have published the research work: Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug target, in the Journal: (JOURNAL) of May/24,/2022
- what: The authors report that three evolutionarily-distinct BioH isoenzymes (BioH1 to BioH3) are programmed in biotin synthesis of Mycobacterium smegmatis. The authors determine the crystal structure of dimeric BioH3 at 2.27u00c5 featuring a unique lid domain. To seek how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.